High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

Massimo Puoti, Graham R. Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Tsung Chang, Samuel S. Lee, Rui Marinho, Jean Francois Dufour, Stanislas Pol, Christophe Hezode, Stuart C. Gordon, Simone I. Strasser, Paul J. Thuluvath, Zhenzhen Zhang, Sandra Lovell, Tami Pilot-Matias, Federico J. Mensa

Research output: Contribution to journalArticlepeer-review

76 Citations (Scopus)

Fingerprint Dive into the research topics of 'High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis'. Together they form a unique fingerprint.

Medicine & Life Sciences